CervoMed (CRVO) Cash from Investing Activities (2010 - 2026)

CervoMed has reported Cash from Investing Activities for 11 years, with the latest figure at $7.7 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 42.88% year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.4 million (up 187.74% YoY) and the FY2025 annual result came in at $18.1 million, up 163.14% from the prior year.
• Cash from Investing Activities rose to $7.7 million in Q1 2026 per CRVO's latest filing, from $5.4 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $9.5 million in Q1 2023 and troughed at -$40.6 million in Q2 2024.
• A 5-year average of -$1.1 million and a median of $4.4 million in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities surged 174900.0% in 2022, then plunged 9544.28% in 2023.
• Over 5 years, Cash from Investing Activities stood at $7.0 million in 2022, then sank by 235.71% to -$9.5 million in 2023, then jumped by 197.97% to $9.3 million in 2024, then plunged by 42.26% to $5.4 million in 2025, then soared by 43.49% to $7.7 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $7.7 million, $5.4 million, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.